CEV
Eaton Vance California MIT
10.10$
+1.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.3% | -2.4% | -2.1% | -2.2% | +5.3% | +2.3% | -0.2% | -23.7% | -9.6% | -3.6% | +8.5% | |
| – | -8.5% | +83.9% | -33.5% | -16.6% | +24.4% | +147.7% | -31.9% | -15.6% | -40.9% | -93.8% | +1,247.9% | |
| – | -100.0% | – | -65.9% | -59.9% | +228.2% | +541.0% | -89.8% | +370.4% | -78.6% | -71.4% | -21.3% | |
| – | -100.0% | – | -65.9% | -59.9% | +228.2% | +541.0% | -89.8% | +370.4% | -78.6% | -71.4% | -21.3% | |
| – | +5.4% | +5.4% | -9.4% | -4.5% | +0.4% | -3.6% | +116.2% | -62.1% | +15.5% | -23.3% | +31.1% | |
| – | – | – | -200.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -11.7% | +359.4% | -7.9% | +10.8% | -0.6% | +1.7% | +0.0% | -27.3% | -26.1% | -17.8% | +50.6% | |
| – | -37.6% | +73.9% | -2.0% | +4,515.5% | -70.4% | +426.9% | -11.8% | -77.7% | -14.6% | +19.4% | +923.0% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -37.6% | +73.9% | -2.0% | +4,515.5% | -70.4% | +362.5% | +0.5% | -77.7% | -14.6% | +19.4% | +923.0% | |
| – | -12.6% | +370.1% | -8.0% | +9.4% | – | – | – | – | – | – | – | |
| – | -0.3% | -33.0% | +1.3% | -9.0% | +9.1% | +2.6% | -0.3% | -21.6% | -0.6% | +2.0% | -5.1% | |
| – | -8.4% | -34.7% | +77.5% | -336.8% | – | +19.7% | -2.1% | -138.2% | – | – | – | |
| – | +0.8% | -4.8% | +5.5% | -3.5% | +0.6% | +0.0% | +0.0% | -0.7% | +0.7% | -1.4% | +0.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.